Germany's Bundestag passes a bill hiking drugmakers' patented-drug discount to 15.5%, aiming to cut €16.3B from 2027 health spending.

Patients, hospitals and drugmakers will shoulder the savings burden

Germany's Bundestag passes a bill hiking drugmakers' patented-drug discount to 15.5%, aiming to cut €16.3B from 2027 health spending.